Unlock instant, AI-driven research and patent intelligence for your innovation.

A fourth-generation car-t cell fused to express type I il-10 receptor and its preparation method and application

An expression vector, cd19scfv-il10rcar-t technology, applied to CAR-T cells and their application in the field of tumor immunotherapy, can solve the problems of T cell exhaustion, CAR-T cells cannot play an anti-tumor effect for a long time, etc. The effect of alleviating T cell exhaustion and reducing the effect of cytokine storm

Active Publication Date: 2022-07-05
WUHAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Type I IL-10 receptor molecules play a role in specific binding to IL-10. With the participation of type II IL-10 receptor molecules and signal transmission, they induce the up-regulated expression of inhibitory immune molecules on T cells, thereby inducing Exhaustion of T cells prevents adoptive CAR-T cells from lastingly exerting anti-tumor effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A fourth-generation car-t cell fused to express type I il-10 receptor and its preparation method and application
  • A fourth-generation car-t cell fused to express type I il-10 receptor and its preparation method and application
  • A fourth-generation car-t cell fused to express type I il-10 receptor and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The features and advantages of the present invention can be further understood from the following detailed description in conjunction with the accompanying drawings. The examples provided are merely illustrative of the methods of the present invention, and are not intended to limit the remainder of the present disclosure in any way. [Example 1] Construction of the fourth-generation novel CAR structure (scFv-IL10R-CD28-4-1BB-CD3ζ) lentiviral expression vector

[0033] 1. A lentiviral expression vector expressing human scFv-IL10R-CD28-4-1BB-CD3ζ;

[0034] Result: as figure 1 shown in A

[0035] A is a lentiviral vector inserted to express the fourth-generation novel CAR structure of scFv-IL10R-CD28-4-1BB-CD3ζ; corresponding to figure 2 Identification by restriction enzyme digestion in lanes 1-5.

[0036] The above-obtained CAR complete structural gene was digested with EcoRI and BamHI, and then ligated with the linearized lentiviral expression plasmid pCDH-CMV-mcs-EF...

Embodiment 2

[0054] [Example 2] CD3 + Acquisition of T cells

[0055] human peripheral blood CD3 + Take the acquisition of T cells as an example.

[0056] 1. Preparation of peripheral blood mononuclear cells (PBMC)

[0057] 1. Take 50 mL of human peripheral blood into an anticoagulation tube, and add an equal volume of PBS to dilute;

[0058] 2. Slowly add the diluted blood into a centrifuge tube containing an equal volume of lymphocyte separation solution, not exceeding 2 / 3 of the total volume of the centrifuge tube, centrifuge at 20°C and 400g / min for 15min (speed 9, speed drop 1);

[0059] 3. Absorb the cloudy liquid into a centrifuge tube, 300g, 5min to remove excess liquid;

[0060] 4. Add 3 mL of erythrocyte lysis solution for lysis for 5 minutes;

[0061] 5. Add 5mL PBS 300g, wash 1-2 times in 5min, set aside.

[0062] Remarks: The reagents and materials used above all need to be aseptically processed in advance.

[0063] 2. Magnetic Bead Sorting CD3 + T cells (Pan T CellBio...

Embodiment 3

[0071] [Example 3] CD3 + Culture, activation of T cells and preparation of CD19 scFv-IL10R CAR-T cells 1. CD3 + Culture and activation of T cells

[0072] 1. Culture medium configuration:

[0073]1640 medium: containing 10% FBS, 2mM glutamine (gluamine), 1% MEM non-essential aminoacid solution, 100uM HEPES (hydroxyethylpiperazine ethanethiosulfonic acid), 1mM sodium pyruvate (sodium pyruvate), 1% antibiotic-antimycotic solution (double antibody);

[0074] 2. Each cell culture plate was pre-coated with anti-CD3 at a working concentration of 5 μg / mL, and the isolated cells were diluted to 10 6 cells / ml, 10ml of diluted cells were added to each plate, supplemented with 2μg / ml anti-CD28 and 50U / ml IL-2, 37°C, 5% CO 2 Continue to cultivate 3d;

[0075] 2. Preparation of CD19 scFv-IL10R CAR-T cells

[0076] 1. Take the required virus out of the -80°C refrigerator 60 minutes in advance, and put it in the 2-8°C refrigerator to melt;

[0077] 2. Turn on the UV light of the biosa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a fourth-generation CAR-T cell fused to express type I IL-10 receptor, and a preparation method and application thereof. The fourth-generation CAR structure (scFv-IL10R-CD28-4-1BB-CD3ζ) was infected with CD3 lentivirus by lentiviral infection method + After T cells, the CD19 scFv-IL10R CAR-T cells that can target and recognize tumor cells are prepared after expansion culture. The CD19 scFv-IL10R CAR-T cell is used as a drug to antagonize the negative immunoregulatory effect of IL-10, relieve T cell exhaustion and weaken the immunosuppressive effect caused by IL-10, and use it to target killing in vitro and in vivo tumor cell growth.

Description

technical field [0001] The invention relates to the technical field of tumor immunotherapy, in particular to a fourth-generation novel CAR structure (scFv-IL10R-CD28-CAR) targeting CD19 B lymphoma by fusion expressing type I IL-10 receptor (IL-10R1). 4-1BB-CD3ζ) CAR-T cells and their application in the field of tumor immunotherapy. Background technique [0002] Chimeric antigen receptor (CAR) technology is a fusion of single-chain antibodies that recognize tumor antigens with the activation sequence of T cells (the intracellular segment of signaling molecules), and uses single-chain antibodies to bind to tumor antigens with high affinity. It not only targets and kills tumors, but also overcomes the immune escape effect of tumor cells down-regulating the expression of MHC molecules and reducing antigen presentation. Although CAR-T cell immunotherapy has great promise in the treatment of hematological tumors, it also has large side effects. In the tumor environment, cells su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/867C12N15/62A61K39/00A61P35/00A61P35/02
CPCC12N5/0636C12N15/86C07K16/2803C07K14/7155C07K14/7051C07K14/70521C07K14/70578A61K39/001112A61P35/00A61P35/02C12N2510/00C12N2740/15043C12N2800/107C07K2317/622C07K2319/33C07K2319/74C07K2319/00A61K2039/5156A61K2039/804
Inventor 章晓联刘传刚
Owner WUHAN UNIV